Detalhe da pesquisa
1.
Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy.
World J Surg Oncol
; 21(1): 291, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715254
2.
Loss of STING expression is prognostic in non-small cell lung cancer.
J Surg Oncol
; 125(6): 1042-1052, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35099823
3.
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence.
Future Oncol
; 18(8): 903-913, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073733
4.
Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA.
Adv Exp Med Biol
; 924: 139-146, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27753035
5.
Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial.
J Thorac Oncol
; 18(1): 93-105, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184068
6.
Combined BRAF and MEK inhibition in BRAF-mutant NSCLC.
Lancet Oncol
; 17(7): 860-862, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283865
7.
A case of hyperprolactinaemia in a patient with metastatic melanoma.
Melanoma Res
; 31(3): 277-279, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904520
8.
Cardiac Troponin I and T in Checkpoint Inhibitor-associated Myositis and Myocarditis.
J Immunother
; 44(4): 162-163, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416262
9.
Pulmonary barotrauma and cerebral arterial gas embolism during hyperbaric oxygen therapy.
Aviat Space Environ Med
; 81(9): 888-90, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20824998
10.
Osimertinib in NSCLC: Real-World Data From New Zealand.
JTO Clin Res Rep
; 1(2): 100022, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589929
11.
Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.
Transl Lung Cancer Res
; 9(3): 639-645, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676326
12.
NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
Lung Cancer
; 146: 154-159, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32540558
13.
Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease.
J Thorac Dis
; 11(5): 1756-1764, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285867
14.
Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.
Transl Lung Cancer Res
; 8(2): 167-175, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106127
15.
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.
Lung Cancer
; 125: 115-120, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429008
16.
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma.
J Thorac Oncol
; 13(11): 1784-1791, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142389
17.
Standard of care in immunotherapy trials: Challenges and considerations.
Hum Vaccin Immunother
; 13(9): 2164-2178, 2017 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267397
18.
Current role of sentinel lymph node biopsy in early-stage melanoma.
N Z Med J
; 135(1557): 97-99, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772118
19.
Combination approaches in NSCLC involving immune checkpoint inhibitors.
Lung Cancer Manag
; 5(4): 163-171, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30643561
20.
Update on Mucin-1 immunotherapy in cancer: a clinical perspective.
Expert Opin Biol Ther
; 15(12): 1773-87, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26453294